Expression in Pichia pastoris and purification of a membrane-acting immunotoxin based on a synthetic gene coding for the Bacillus thuringiensis Cyt2Aa1 toxin

Protein Expression and Purification

Volumn 29, Issue 1, 2003, Pages 103-116

  Gurkan, Cemal ^a,b   Ellar, David J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACILLUS THURINGIENSIS; BACTERIA (MICROORGANISMS); EUKARYOTA; PICHIA; PICHIA PASTORIS; SYNTHETIC CONSTRUCT;

EID: 0037855845     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1046-5928(03)00012-3     Document Type: Article

References (50)

1. G.R. Thrush, L.R. Lark, B.C. Clinchy, E.S. Vitetta, Immunotoxins: an update, Annu. Rev. Immunol. 14 (1996) 49-71.
2. R.J. Kreitman, Immunotoxins in cancer therapy, Curr. Opin. Immunol. 11 (1999) 570-578.
3. F.A. Drobniewski, Immunotoxins up to the present day, Biosci. Rep. 9 (1989) 139-156.
4. A.D. Avila, C. Mateo de Acosta, A. Lage, A carcinoembryonic antigen-directed immunotoxin built by linking a monoclonal antibody to a hemolytic toxin, Int. J. Cancer 43 (1989) 926-929.
5. R.D. Dunn, KM. Weston, T.J. Longhurst, G.G. Lilley, D.E. Rivett, P.J. Hudson, R.L. Raison, Antigen binding and cytotoxic properties of a recombinant immunotoxin incorporating the lytic peptide, melittin, Immunotechnology 2 (1996) 229-240.
6. W.E. Thomas, D.J. Ellar, Bacillus thuringiensis var israelensis crystal δ-endotoxin: effects on insect and mammalian cells in vitro and in vivo, J. Cell. Sci. 60 (1983) 181-197.
7. P.A. Koni, D.J. Ellar, Cloning and characterization of a novel Bacillus thuringiensis cytolytic δ-endotoxin, J. Mol. Biol. 229 (1993) 319-327.
8. P.A. Koni, D.J. Ellar, Biochemical characterization of Bacillus thuringiensis cytolytic δ-endotoxins, Microbiology 140 (1994) 1869-1880.
9. J. Du, B.H. Knowles, J. Li, D.J. Ellar, Biochemical characterization of Bacillus thuringiensis cytolytic toxins in association with a phospholipid bilayer, Biochem. J. 338 (1999) 185-193.
10. B. Promdonkoy, D.J. Ellar, Membrane pore architecture of a cytolytic toxin from Bacillus thuringiensis, Biochem. J. 350 (2000) 275-282.
11. J. Li, P.A. Koni, D.J. Ellar, Structure of the mosquitocidal δ-endotoxin CytB from Bacillus thuringiensis sp. kyushuensis and implications for membrane pore formation, J. Mol. Biol. 257 (1996) 129-152.
12. J. Li, D.J. Derbyshire, B. Promdonkoy, D.J. Ellar, Structural implications for the transformation of the Bacillus thuringiensis δ-endotoxins from water-soluble to membrane-inserted forms, Biochem. Soc. Trans. 29 (2001) 571-577.
13. S.A. al-yahyaee, D.J. Ellar, Cell targeting of a pore-forming toxin, CytA δ-endotoxin from Bacillus thuringiensis subspecies israelensis, by conjugating CytA with anti-Thy 1 monoclonal antibodies and insulin, Bioconjug. Chem. 7 (1996) 451-460.
14. D.J. Park, Development of a novel membrane-acting immunolysin. Ph.D. Thesis, Department of Biochemistry, University of Cambridge, 1998.
15. J.L. Cereghino, J.M. Cregg, Heterologous protein expression in the methylotrophic yeast Pichia pastoris, FEMS Microbiol. Rev. 24 (2000) 45-66.
16. C. Gürkan, D.J. Ellar, Design and construction of membrane-acting immunotoxins based on the Bacillus thuringiensis δ-endotoxin Cyt2Aa1 for expression in Pichia pastoris, Med. Microbiol. Immun. 189 (2000) 37 (abstract).
17. D.J. Slamon, W. Godolphin, L.A. Jones, J.A. Holt, S.G. Wong, D.E. Keith, W.J. Levin, S.G. Stuart, J. Udove, A. Ullrich, et al., Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer, Science 244 (1989) 707-712.
18. R. Schier, J.D. Marks, E.J. Wolf, G. Apell, C. Wong, J.E. McCartney, M.A. Bookman, J.S. Huston, L.L. Houston, L.M. Weiner, et al., In vitro and in vivo characterization of a human anti-c-erbB-2 single-chain Fv isolated from a filamentous phage antibody library, Immunotechnology 1 (1995) 73-81.
19. M.G. Rosenblum, L.K. Shawver, J.W. Marks, J. Brink, L. Cheung, B. Langton-Webster, Recombinant immunotoxins directed against the c-erb-2/HER2/neu oncogene product: in vitro cytotoxicity, pharmacokinetics, and in vivo efficacy studies in xenograft models, Clin. Cancer Res. 5 (1999) 865-874.
20. C. Gurkan, Design and construction of membrane-acting immunotoxins for intracellular and secreted protein expression in Pichia pastoris. M.Phil. Thesis, Department of Biochemistry, University of Cambridge, 1999.
21. M.A. Romanos, A.J. Makoff, N.F. Fairweather, K.M. Beesley, D.E Slater, F.B. Rayment, M.M. Payne, J.J. Clare, Expression of tetanus toxin fragment C in yeast: gene synthesis is required to eliminate fortuitous polyadenylation sites in AT-rich DNA, Nucleic Acids Res. 19 (1991) 1461-1467.
22. C.A. Scorer, R.G. Buckholz, J.J. Clare, M.A. Romanos, The intracellular production and secretion of HIV-1 envelope protein in the methylotrophic yeast Pichia pastoris, Gene 136 (1993) 111-119.
23. K. Sreekrishna, WD. Prevatt, G.P. Thill, G.R. Davis, P. Koutz, K.A. Barr, S.A. Hopkins, Production of Bacillus entomotoxins in methylotrophic yeast. US Patent Document 5, 827, 684 (1998).
24. C. Withers-Martinez, E.P. Carpenter, F. Hackett, B. Ely, M. Sajid, M. Grainger, M.J. Blackman, PCR-based gene synthesis as an efficient approach for expression of the A + T-rich malaria genome, Protein Eng. 12 (1999) 1113-1120.
25. C. Prodromou, L.H. Pearl, Recursive PCR: a novel technique for total gene synthesis, Protein Eng. 5 (1992) 827-829.
26. M.D. Williams, A. Rostovtsev, R.K. Narla, F.M. Uckun, Production of recombinant DTctGMCSF fusion toxin in a baculovirus expression vector system for biotherapy of GMCSF-receptor positive hematologic malignancies, Protein Expr. Purif. 13 (1998) 210-221.
27. Y.Y. Liu, I. Gordienko, A. Mathias, S. Ma, J. Thompson, J.H. Woo, D.M. Neville Jr., Expression of an anti-CD3 single-chain immunotoxin with a truncated diphtheria toxin in a mutant CHO cell line, Protein Expr. Purif. 19 (2000) 304-311.
28. A.B. Choo, R.D. Dunn, K.W. Broady, R.L. Raison, Soluble expression of a functional recombinant cytolytic immunotoxin in insect cells, Protein Expr. Purif. 24 (2002) 338-347.
29. J.H. Woo, Y.Y. Liu, A. Mathias, S. Stavrou, Z. Wang, J. Thompson, D.M. Neville, Gene optimization is necessary to express a bivalent anti-human anti-T cell immunotoxin in Pichia pastoris, Protein Expr. Purif. 25 (2002) 270-282.
30. J.L. Bennetzen, B.D. Hall, Codon selection in yeast, J. Biol. Chem. 257 (1982) 3026-3031.
31. J.F. Ernst, Codon usage and gene expression, Trends Biotechnol. 6 (1988) 196-199.
32. S.B. Baim, F. Sherman, mRNA structures influencing translation in the yeast Saccharomyces cerevisiae, Mol. Cell. Biol. 8 (1988) 1591-1601.
33. I.B. Sears, J. O'Connor, O.W. Rossanese, B.S. Glick, A versatile set of vectors for constitutive and regulated gene expression in Pichia pastoris, Yeast 14 (1998) 783-790.
34. J. Haaning, C. Oxvig, M.T. Overgaard, L. Sottrup-Jensen, Simple and reliable procedure for PCR amplification of genomic DNA from yeast cells using short sequencing primers, Biochem. Mol. Biol. Int. 42 (1997) 169-172.
35. L.M. Jost, J.M. Kirkwood, T.L. Whiteside, Improved short- and long-term XTT-based colorimetric cellular cytotoxicity assay for melanoma and other tumor cells, J. Immunol. Methods 147 (1992) 153-165.
36. N.G. Abdulaev, M.P. Popp, W.C. Smith, KD. Ridge, Functional expression of bovine opsin in the methylotrophic yeast Pichia pastoris, Protein Expr. Purif. 10 (1997) 61-69.
37. H. Zhu, J. Shi, Y. de Vries, D.N. Arvidson, J.M. Cregg, G. Woldegiorgis, Functional studies of yeast-expressed human heart muscle carnitine palmitoyltransferase I, Arch. Biochem. Biophys. 347 (1997) 53-61.
38. H.M. Weiss, W. Haase, H. Michel, H. Reilander, Comparative biochemical and pharmacological characterization of the mouse 5HT5A 5-hydroxytryptamine receptor and the human β2-adrenergic receptor produced in the methylotrophic yeast Pichia pastoris, Biochem. J. 330 (1998) 1137-1147.
39. D. Sinha, M. Bakhshi, R. Vora, Ligand binding assays with recombinant proteins refolded on an affinity matrix, Biotechniques 17 (1994) 509-512, 514.
40. A. Holzinger, K.S. Phillips, T.E. Weaver, Single-step purification/solubilization of recombinant proteins: application to surfactant protein B, Biotechniques 20 (1996) 804-806, 808.
41. A. Negro, M. Onisto, L. Masiero, S. Garbisa, Synthesis and refolding of human TIMP-2 from E. coli, with specific activity for MMP-2, FEBS Lett. 360 (1995) 52-56.
42. A. Negro, M. Onisto, L. Grassato, C. Caenazzo, S. Garbisa, Recombinant human TIMP-3 from Escherichia coli: synthesis, refolding, physico-chemical and functional insights, Protein Eng. 10 (1997) 593-599.
43. H. Rogl, K. Kosemund, W. Kuhlbrandt, I. Collinson, Refolding of Escherichia coli produced membrane protein inclusion bodies immobilised by nickel chelating chromatography, FEBS Lett. 432 (1998) 21-26.
44. S. Misawa, I. Kumagai, Refolding of therapeutic proteins produced in Escherichia coli as inclusion bodies, Biopolymers 51 (1999) 297-307.
45. D. Julius, R. Schekman, J. Thorner, Glycosylation and processing of prepro-α-factor through the yeast secretory pathway, Cell 36 (1984) 309-318.
46. X. Chen, C. Van Valkenburgh, H. Liang, H. Fang, N. Green, Signal peptidase and oligosaccharyltransferase interact in a sequential manner within the endoplasmic reticulum, J. Biol. Chem. 276 (2001) 2411-2416.
47. W. Dowhan, Membrane phospholipid diversity: why are there so many lipids?, Annu. Rev. Biochem. 66 (1997) 199-232.
48. B.H. Knowles, M.R. Blatt, M. Tester, J.M. Horsnell, J. Carroll, G. Menestrina, D.J. Ellar, A cytolytic δ-endotoxin from Bacillus thuringiensis var. israelensis forms cation-selective channels in planar lipid bilayers, FEBS Lett. 244 (1989) 259-262.
49. J. Lippincott-Schwartz, T.H. Roberts, K. Hirschberg, Secretory protein trafficking and organelle dynamics in living cells, Annu. Rev. Cell Dev. Biol. 16 (2000) 557-589.
50. A. Schouten, J. Roosien, F.A. van Engelen, G.A.M.I. de Jong, A.W.M. Borst-Vrenssen, J.F. Zilverentant, D. Bosch, W.J. Stiekema, F.J. Gommers, A. Schots, J. Bakker, The C-terminal KDEL sequences the expression level of a single chain antibody designed to be targeted to both the cytosol and the secretory pathway in transgenic tobacco, Plant Mol. Biol. 30 (1996) 781-793.